Dr. Mayse is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4960 Childrens Pl
Saint Louis, MO 63110Phone+1 314-454-8917Fax+1 314-454-5571
Education & Training
Yale-New Haven Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1999 - 2002- Yale-New Haven Medical CenterResidency, Internal Medicine, 1996 - 1999
Yale School of MedicineClass of 1996
Certifications & Licensure
MO State Medical License 2003 - 2025
Publications & Presentations
PubMed
- Correction to: Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomesChristophe Pison, Pallav L. Shah, Dirk-Jan Slebos, Vincent Ninane, Wim Janssens
Respiratory Research. 2021-02-19 - 8 citationsSafety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomes.Christophe Pison, Pallav L. Shah, Dirk-Jan Slebos, Vincent Ninane, Wim Janssens
Respiratory Research. 2021-02-19 - 9 citationsTargeted lung denervation in sheep: durability of denervation and long-term histologic effects on bronchial wall and peribronchial structures.Martin L. Mayse, Holly S. Norman, Alexander D. Peterson, Kristina Rouw, Philip J. Johnson
Respiratory Research. 2020-05-18
Press Mentions
Nuvaira Announces Oral Presentation at ERS International Congress Discussing Significance of Targeted Lung Denervation to Treat COPDSeptember 18th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
